Dare Bioscience, Inc. Increase (Decrease) in Accounts Receivable
Dare Bioscience, Inc. (DARE) reported Increase (Decrease) in Accounts Receivable of -$3.19 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-13
- Dare Bioscience, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$123.83K.
- Dare Bioscience, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $120.63K.
- Dare Bioscience, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-06-30 was $0.00.
- Dare Bioscience, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Dare Bioscience, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $12.05K.
- Dare Bioscience, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $0.00.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|
| 2026-06-30 | -$123.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$3.19K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $120.63K 10-Q · filed 2026-05-14 | ||
| 2025-12-31 | $12.05K 10-K · filed 2026-03-26 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-03-26 | ||
| 2024-06-30 | -$39.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $27.98K 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $67.64K 10-Q · filed 2025-05-13 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $0.00 10-Q · filed 2024-08-12 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-14 | ||
| 2022-06-30 | $10.00M 10-Q · filed 2023-08-10 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-09 | ||
| 2017-03-31 | $316.00K 10-Q · filed 2017-05-12 | ||
| 2016-03-31 | $18.00K 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |